10-12 april 2024 - Helsingborg, Sweden

Maudsley Forum Scandinavia

We are looking forward to seeing you soon!

Sorry, registration is closed.

Questions concerning registration or your participation can be emailed to: maudsley.forum.scandinavia@skane.se

About Maudsley Forum Scandinavia

Region Skåne University Hospital for adult psychiatry Helsingborg, in collaboration with King’s College London and Lund University’s
department for child and adolescent psychiatry proudly present an intensive, three-day state-of-the-art educational conference.

World-class speakers, leading experts from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London and distinguished Scandinavian clinicians and researchers, with a worldwide reputation for psychiatric research and clinical care, will meet in Helsingborg and present cutting edge advances in clinical and academic psychiatry. The Forum will provide a top-level update on social, psychological and biological aspects of psychiatric disorders, reviewing advances in diagnostics and new methods of treatment.

It consists of a broad spectrum of lectures, in the fields of Adult Psychiatry, Forensic Psychiatry and Child and Adolescent Psychiatry, addressing topics such as psychotic and mood disorders, addiction, pharmacological and psychological treatment interventions, genetics and epigenetics in psychiatry, neuroimaging and neurocognition. 

Please note that the lectures are held in English.

Following up the success in 2022

The establishment of the first Maudsley Forum Scandinavia was orchestrated by Professor Sir Robin Murray, Professor Allan Young and Associate Professor Jonas Eberhard, from the Institute of Psychiatry, Psychology & Neuroscience, King's College London and Lund University, Sweden.

Our intention is that this conference will become an annual, long-lasting tradition, introducing a Forum for networking, exchange of ideas and cooperation.

The conference is primarily intended for psychiatrists - specialists and residents, but also for clinical psychologists, mental health professionals as well as neuroscientists and students.  

Fees 
Conference: 7 900 SEK
Optional dinner: 650 SEK

For further information, please contact:
maudsley.forum.scandinavia@skane.se
 

Programme

Event Schedule - 10 April

Preliminary programme, subject to changes.

Morning 10 April
  • 8:30 - 9:00 am - Registration

    9:00 - 9:45 am - Introduction
  • 9:45 - 10:30 am - Professor Allan Young

    The treatment of depression: what does the future hold?  

    Moderator: Jonas Eberhard

  • 10:30 - 11:00 am - Fika Pause
  • 11:00 - 11:45 am - Professor Robin Murray

    An aetiological approach to the treatment of psychosis

    Moderator: Johannes Lundström Hammar

  • 11:45 - 12:30 am -  Dr Ruchika Gajwani

    From affective dysregulation to pathology: Neurodevelopment problems and trauma in young people, at risk of serious mental illness.

    Moderator: Max Thorsson

Afternoon 10 April
  • 12:30 - 1:30 pm - Lunch
  • 1:30 - 2:15 pm -  Professor Fiona Gaughran

    Inequalities and physical health in Severe Mental Illness

    Moderator: Richard Stenmark

  • 2:15-2:45 pm - Fika Pause
  • 2:45-3:30 pm - Dr. Maurits Johansson

    Role of neuropsychiatric symptoms as markers for Alzheimers´s disease in an era of disease modifying treatments

    Moderator: Carina Tordai

  • 3:30-4:15 pm  - Associate Professor Jonas Eberhard

    Psychiatric horizons: from Helsingborg to Copenhagen – pharmaceutical innovations and development

Evening 10 April
  • 4:30 pm - Mingle at Marina Plaza

Event Schedule - 11 April

Preliminary programme, subject to changes.

Morning 11 April
  • 9:00 - 9:45 am - Dr Martha di Forti 

    Cannabis and Psychosis: past, present and future

    Moderator: Hampus Nyberg Berisha

  • 9:45 - 10:30 am - Professor Martin Balslev Jørgensen

    Are bensodiazapines dangerous?

    Moderator: Steinn Steingrimsson
     

  • 10:30 - 11:00 am - Fika Pause
  • 11:00 - 11:45 am - Associate Professor Daniel Lindqvist

    Can novel trial designs advance depression treatment?

    Moderator: Marcus Persson

  • 11:45 - 12:30 am - Dr. James Rucker 

    Our work with psilocybin and MDMA

    Moderator: Joakim Ekstrand

Afternoon 11 April
  • 12:30 - 1:30 pm - Lunch
  • 1:30 - 2:15 pm -  Professor Edgar Jones  

    Right-wing extremism in Europe: a psychiatric or a political challenge?

    Moderator: Andreas Traunsberger

  • 2:15 - 2:45 pm - Fika Pause
  • 2:45 - 3:30 pm - Associate Professor  Julie Nordgaard

    Self Disorders and Psychosis

    Moderator: Måns Lindén

  • 3:30 - 4:15 pm - Professor Neera Ghaziuddin

    Management of catatonia with focus on ECT

    Moderator: Merve Cingi Yirûn

Evening 11 April
  • 5:30 pm - Dinner cruise 

    Gathering 5:30 pm at Marina Plaza hotel lobby

Event Schedule - 12 April

Preliminary programme, subject to changes.

Morning 12 April
  • 9:00 - 9:45 am - Professor Mohammad Ghaziuddin 

    Managing mental illness in persons with ASD:A practitioner´s view

    Moderator: Johan Nyrenius

  • 9:45 - 10:30 am - Dr. Mariana Pinto da Costa 

    Social isolation, loneliness and Hikikomori - navigating the spectrum of social connection

    Moderator: Sophia Eberhard

  • 10:30 - 11:00 am - Fika Pause
  • 11:00 - 11:45 am - Associate Professor Åsa Konradsson 

    The importance of gender-specific antipsychotic medication

    Moderator: Karin Tunér

  • 11:45 - 12:30 am - Professor Graham Murray 
     

    Personalized Psychiatry using routinely collected data

    Moderator: Johan Nyrenius

Afternoon 12 April
  • 12:30 - 1:30 pm - Lunch
  • 1:30 - 2:15 pm -  Associate Professor Christian Benedict

    Sleep and Alzheimer

    Moderator: Viktor Fabri

  • 2:15 - 2:45 pm - Fika Pause 
  • 2:45 - 3:30 pm - Panel discussion 

    Progress, problems, prospects and expectations

Speakers 2024

Dr Mariana Pinto da Costa is a Consultant Psychiatrist at South London and Maudsley NHS Foundation Trust (SLaM), a Senior Lecturer at the Institute of Psychiatry, Psychology & Neuroscience, King’s College London, and an Invited Professor at the Institute of Biomedical Sciences Abel Salazar at the University of Porto.  

She is the Chair of the Section on Public Mental Health of the European Psychiatric Association, and the Secretary of the Section on Education of the World Psychiatric Association. She was president of the European Federation of Psychiatry Trainees, and Principal Investigator of the Brain Drain Study, researching mobility experiences of psychiatry trainees in Europe. She also has professional experience in Africa, where she was screening alcohol, smoking and other substances involvement, in primary and mental health care service users in Luanda, while studying for the International Masters on Mental Health Policy and Services at the New University of Lisbon supported by the WHO. 
She is the Champion for Culture, Equality, Diversity and Inclusion at the NIHR Maudsley Biomedical Research Centre, member of the Executive of the NIHR ARC South London, and member of the R&D panel of adult mental health services at SLaM. She is the Academic Lead of the Digital Psychiatry Special Interest Group of the Royal College of Psychiatrists. She is part of the Editorial Board of the British Journal of Psychiatry, Psychiatric Services and Plos One.  
Mariana Pinto da Costa 

Dr.

Professor Allan Young holds the Chair of Mood Disorders and is Director of the Centre for Affective Disorders in the Department of Psychological Medicine in the IoPPN, King’s College London. Research focus on the cause and treatments for severe psychiatric illnesses, particularly mood disorders. He has received research grant funding from the UK Medical Research Council, the Stanley Medical Research Institute, the Canadian Institutes for Heath Research, the National Institutes of Health (USA) and numerous other agencies. He has published over 700 publications and a number of books. 
Allan Young

Professor

Fiona Gaughran is Professor of Physical Health and Clinical Therapeutics in Psychiatry at the Institute of Psychiatry, Psychology and Neuroscience, King’s College London and the Director of Research and Development at the South London and Maudsley NHS Foundation Trust, where she is the Lead Consultant for the National Psychosis Service. She is also the Theme lead for Applied Informatics in the NIHR Applied Research Collaboration in South London. Professor Gaughran holds fellowships of the Royal Colleges of Physicians in London, Edinburgh and Dublin and the Royal College of Psychiatrists. Her research interests are largely focused on the interface between physical health and serious mental illness and on the management of psychosis. Since 2020, Professor Gaughran has been on the Clarivate Highly Cited Researchers list, meaning she ranks among the top 1% most cited for her subject field and year of publication.
Fiona Gaughran

Professor

James Rucker is a Consultant Psychiatrist and a Senior Clinical Lecturer in mood disorders and psychopharmacology at the Centre for Affective Disorders at the Institute of Psychiatry, Psychology & Neuroscience at King’s College London (UK). James completed his medical degree at University College London (UK) in 2003 before training in psychiatry at the Maudsley, Bethlem and Springfield Hospitals in South London. He completed his PhD in the molecular biology of mood disorders at King’s College London in 2012. He specialises clinically and academically in mental health problems predominantly associated with mood and is particularly interested in novel drug treatments and drug assisted forms of therapy in treatment resistant forms of depression, anxiety and trauma response syndromes. He leads the Psychoactive Trials Group at King’s College London, which specialises in clinical trials using psilocybin, MDMA and related compounds. He is co-director of the Centre for Mental Health Research and Innovation at the South London and Maudsley NHS Trust, a dedicated research facility for clinical trials of psilocybin therapy, and a model ‘clinic of the future’. Clinically, he works with Professor Allan Young at the National Affective Disorders Service, which is a specialist NHS treatment centre at South London and Maudsley NHS Trust. He is also expert in the use of Cannabis Based Medicinal Products for mental health problems, having worked for Sapphire Medical, the first CQC-approved medical cannabis clinic since its inception in 2019.  
James Rucker

Consultant Psychiatrist, Senior Clinical Lecturer

Dr Graham Murray is Professor of Psychiatry and Neuroscience at University of Cambridge and Consultant Psychiatrist in the Cambridge early intervention in psychosis service, CAMEO, part of Cambridgeshire and Peterborough NHS Trust. He trained in the UK (Oxford, London and Cambridge) and Finland (Oulu). His research focusses on the causes, mechanisms and treatment of mental illness (mainly psychosis). He uses a variety of research methods, including epidemiology, neuroscience, computational psychiatry, genomics, electronic health records and clinical trials. An important recent part of his work is to improve the infrastructure for psychosis translational research in the UK, through jointly leading the early psychosis workstream of the UK Mental Health Mission.
Graham Murray

Professor

Dr Ruchika Gajwani is a Senior Research Fellow and in Clinical Psychology and co-director of the Centre of Developmental Adversity and Resilience (CeDAR) at the University of Glasgow. She is leading complex clinical trials in adolescent mental health for some of the most vulnerable and excluded children and young people and her current work is focussing on testing community trials for young people with Borderline Personality Disorder features (BRIDGE project). Through partnership working and collaborations, the team is building a research portfolio on innovative solutions, scaling up proven treatments, and ensuring they reach those who need them most.  Her research focus for the last twenty years has been on developing pathways for understanding risk and resilience within marginalised, clinical high-risk children and young people. She has conducted genetic, longitudinal and qualitative research on the role of developmental adversities and neurodevelopmental conditions on health outcomes. 
Ruchika Gajwani

Dr.

Åsa Konradsson-Geuken, Associate Professor in Pharmacology, Department of Pharmaceutical Biosciences, Uppsala University & Helsingborg Clinical Science dept 
Åsas research focuses on finding new treatments that could reduce the recurring psychoses, increase the quality of life and longevity of patients with schizophrenia. The purpose of her studies is to use unique techniques to clarify how drugs, drug candidates and new combinations of molecules affect higher cognitive processes in the brain. These studies may increase our understanding of the neurobiology behind schizophrenia and thereby facilitate the development of new effective drugs.
Åsa Konradsson

Associate Professor in Pharmacology 

Julie Nordgaard, MD, PhD, and M.D.sc is Associated Professor at University of Copenhagen, Denmark and Head of research in Psychopathology, Mental Health Center Amager, Copenhagen.
The key point for her research is psychopathology and the psychiatric diagnostic interview from a phenomenologically informed base with focus on the subjective experiences. Especially disorders within the schizophrenia spectrum have been in focus. She has contributed considerably to the empirical substantiation of self-disorders in schizophrenia spectrum disorders.
Dr. Nordgaard is president of the European Association of Phenomenology, Psychopathology and Psychopathology, she is chairman for Institute of Psychopathology and Director of all EASE (Examination of Anomalous Self-Experiences) related activities.
Dr. Nordgaard teaches at expert level in psychopathology and the psychiatric interview, both internationally and domestic.
She is the author of more than 70 peer-reviewed journal articles, e.g., ‘Self-disorders and psychopathology: a systematic review’ (2021; Lancet Psychiatry); ‘Are self-disorders in schizophrenia expressive of a unifying disturbance of subjectivity: a factor analytic approach’ (2022; Schizophrenia Bulletin); and ‘Psychiatric comorbidity: A concept in need of a theory’ (2023, Psychological Medicine). Dr. Nordgaard is co-PI on several ongoing international research projects.  
Julie Nordgaard

Associate Professor

Professor in the History of Medicine & Psychiatry at King’s College London. Edgar Jones is an authority on the psychological effects of modern war and conflict. He has studied both conventional armed forces and terrorism, exploring how individuals cope during periods of intense stress and the impact of traumatic experiences on their wellbeing. More recently he has researched moral injury, an enduring belief of being wronged or having been compelled to act in ways that feel wrong, in servicemen and women. Edgar Jones has also published on risk factors for radicalisation and support of political violence. He has written extensively on shell shock, post-traumatic stress disorder and chronic multi-symptom illness suffered as a result of military service. The author of a number of reports for government and military or mental health charities, his work seeks to shape policy and practice.  
Edgar Jones

Professor

Daniel Lindqvist is associate professor of psychiatry at Lund University and head of research at the Office for Psychiatry and Habilitation, Region Skåne. Dr Lindqvist leads the Unit for Biological and Precision Psychiatry at Lund University. By using blood, brain, and feces biomarkers Dr Lindqvist’s group want to delineate specific subgroups of depression, and test the antidepressant efficacy of various interventions targeting these specific biological pathways. The goal of this research program is to advance precision psychiatry by tailoring antidepressant treatments.
Daniel Lindqvist

Associate Professor

Sir Robin Murray, Professor of Psychiatric Research at the IoPPN. Particular interest is in psychosis and has contributed to the understanding that environmental factors dysregulate striatal dopamine and thus increase the risk of schizophrenia-like psychoses. He is also involved in testing new treatments for psychotic illnesses, and cares for people with psychosis at the SLaM NHS Foundation Trust. Written over 700 articles. Most frequently cited schizophrenia researcher outside the USA. Has supervised 52 PhDs and 40 of his students have become full professors. Elected a Fellow of the Royal Society in 2010 and received a knighthood in 2011.
Sir Robin Murray

Professor

Danish psychiatrist, professor and researcher as well as Editor-in-chief of Nordic Journal of Psychiatry. Published numerous papers including research in the theory of excitotoxic mechanisms in neuronal necrosis, ECT and the biology and treatment of depression. 
Martin Balslev Jørgensen

Professor

Dr Marta Di Forti is a Senior Lecturer at the Dept of Social, Developmental and Genetic Research, Institute of Psychiatry, and Honorary Consultant Adult Psychiatrist, Lambeth Community team, South London and Maudsley NHS foundation Trust. She leads the first and only Cannabis Clinic for patients with Psychotic disorders in UK. She was recently awarded a MRC Senior Research Fellowship to expand her research in the role of cannabis use in psychosis and its underlying biology. With her team she showed for the first time that use of high potency types of cannabis e.g. "skunk" carries a higher risk of psychosis than use of traditional types and that it affects rates of Psychotic disorders across Europe. Though it still remains unclear who are those cannabis use most at risk. Her future work aims to investigate the interaction between cannabis use and genes predisposing to schizophrenia, and how cannabis changes the epigenome.
Marta Di Forti

Dr.

Mohammad Ghaziuddin, MD, is a Professor of Child and Adolescent Psychiatry at the University of Michigan, Ann Arbor, USA.  He is also a practicing clinician, an educator, and a researcher.  His areas of interest include diagnosis of ASD and its comorbidity.  He was among the earliest to publish on the co-occurrence of psychiatric disorders in persons with autism.
Mohammad Ghaziuddin

Professor

Maurits Johansson serves as a Postdoctoral Fellow within the Clinical Memory Unit (the BioFINDER Study Team) at Lund University and as a Clinical Fellow at the Department of Cognitive Medicine, Ängelholm Hospital, Sweden. His research endeavors, which reside at the intersection of cognitive medicine and geriatric psychiatry, have initially focused on neuropsychiatric symptoms manifesting in the early stages of Alzheimer's disease. Ongoing projects aim to enhance the clinical utility of identifying neuropsychiatric symptoms, deepen the understanding of their underlying neurobiological mechanisms, and investigate the role of neurodegenerative and cognitive deficits in clinical geriatric psychiatry”.
Maurits Johansson

Dr

Christian Benedict is a distinguished figure in the field of neuroscience and pharmacology, holding the positions of Associate Professor of Neuroscience and University. Lecturer in Pharmacology at Uppsala University. Benedict has made significant contributions to the understanding of the impact of sleep and sleep deprivation on health and performance; the link between prolonged sleep disturbances and increased nighttime blood pressure with a heightened risk of Alzheimer's disease; consequences of acute sleep deprivation on elevated levels of substances associated with Alzheimer's and traumatic brain injury. Benedict's research has also shed light on the long-lasting performance impairments caused by shift work and the role of disrupted sleep in weight gain and metabolic disorders. His publications have garnered over 12,000 citations on Google Scholar, accompanied by an h-index of 60 as of 2023.
Christian Benedict

Associate Professor

Dr Ghaziuddin is a child and adolescent (C&A) psychiatrist and a tenured professor at the University of Michigan Ann Arbor.  She has practiced C&A psychiatry for almost 30 years with a focus on severe and treatment refractory psychiatric disorders in youth. Dr Ghaziuddin trained as a psychiatrist in Britain where she became a Member of the Royal College of Psychiatrist after attaining the MRCP(Psych).  She subsequently trained as a C&A psychiatrist at the University of Michigan followed by being appointed as a faculty member.  She is currently the director of a pediatric Electroconvulsive Therapy and Treatment Resistant Disorder Clinic within the child and adolescent psychiatry section. Her research and clinical interests include treatment refractory mood disorders, the use of electroconvulsive therapy (ECT) and catatonia in youth.  One of her key works includes the AACAP Practice Parameters involving the use of ECT, which serve as a blueprint for the use of this modality both nationally and abroad.
Neera Ghaziuddin

Professor

Programme Committee

MD PhD, Associate Professor, Senior lecturer, Consultant psychiatrist, and Head of the Helsingborg Psychiatry research unit at Lund University, Swe­den. Focusing on Epidemiology and clinical trials in Severe Mental Illness JE has worked in psychiatry for 40 years and been involved in Psychiatric treatment research since the early 90ies e.g. as international medical adviser at Lund­beck HQ in Copenhagen. He is vice president and international secretary of the Swedish Psychiatric Association, and national editor for the Nordic Journal of Psychiatry. JE is the author of numerous scientific publications in the areas of psychosis, cognition, and psychiatric-physical co-morbidity, and did his basic medical training at the Ludwig Maximilian University in Munich & Karolinska Institute in Stockholm. He did most of his clinical training and dissertation at Lund University in Sweden, and post-doc training at the IoPPN, King’s College London.
Jonas Eberhard

Associate Professor

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla hendrerit vitae nulla at ultricies. Suspendisse consequat tempor mi, eu tristique mi. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse dignissim convallis dolor at viverra.
Merve Cingi Yirün

Resident Dr.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla hendrerit vitae nulla at ultricies. Suspendisse consequat tempor mi, eu tristique mi. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse dignissim convallis dolor at viverra.
Johannes Lundström Hammar

Resident Dr.

Previous speakers 2022

Sukhi Shergill is Professor of Psychiatry at KMMS and Consultant Psychiatrist and Director of Research at the Kent wide NHS trust (KMPT) since October 2021. He is also Professor of Psychiatry and Systems Neuroscience at the Institute of Psychiatry, Psychology and Neuroscience, King's College London (KCL). He trained in medicine at University College London (UCL), completing a BSc in Psychology before starting his psychiatry training at UCL and completing his higher training at the Maudsley Hospital London. He obtained his PhD at the Institute of Psychiatry KCL and was the recipient of several research fellowships before promotion to Professor in 2014. He heads the Cognition, Schizophrenia and Imaging Laboratory, comprising two-dozen academics, clinical researchers, PhD and other students. He was the founding director of the King’s centre for innovative therapies developing novel therapeutic approaches to mental health between industry and academics/clinicians within KCL. He led the MSc programmes in Mental Health Studies and Organisational Psychiatry and Psychology at KCL for a decade. He has been the recipient of several research and teaching awards; has had extensive grant funding from a range of governmental and charitable sources; published over 250 peer reviewed research publications and supervised more than 20 PhD students.
Sukhi Shergill

Professor

Stephen Bazire is Honorary Professor at the School of Pharmacy, University of East Anglia in Norwich, and a Director of Mistura Enterprise (running the Choice and Medication®) and Mistura Informatics (MaPPs 2®). He was Chief Pharmacist for Norfolk mental health services (1986-2011) and then Consultant Pharmacist in Medicines Management until retiring from the NHS in 2015. He is a Fellow of the Royal Pharmaceutical Society of Great Britain and the College of Mental Health Pharmacy, and was awarded an MBE in 2010 for services to pharmacy and the Guild of Healthcare Pharmacists Gold Medal in 2013. He is a member of David Nutt’s DrugScience Scientific Committee. He is probably best known as the author of the "Psychotropic Drug Directory" (29 editions to 2021 and over half a million copies sold worldwide) and for running the Choice and Medication website. His special clinical interests include depression, bipolar, adult ADHD, and user and carer information and education on medicines. 
Steve Bazire

Professor

Dr Amir Englund has a PhD in Cannabinoid Psychopharamcology from the Institute of Psychiatry, Psychology and Neuroscience at King’s College London. Over the last decade he has conduced several experimental psychopharmacology studies using cannabinoid in healthy volunteers as well as clinical trials with CBD as a treatment for psychosis.
Amir Englund

Dr 

Sebastian Lundström is a licensed psychologist and associate professor of child and adolescent psychiatry who has worked with large-scale epidemiological studies for more than 15 years and conducted several clinical studies. Sebastian also works clinically and investigates younger children with a suspected autism spectrum disorder.
Sebastian Lundström

Associate Professor

Robert Kelly is a psychiatrist affiliated with Cornell University and Lund University, working clinically for New York-Presbyterian Hospital in the United States. He serves as associate editor for Nordic Journal of Psychiatry, Psychiatric Diseases section editor for Brain Sciences, and on committees for the American Psychiatric Association. He conducts research in metascience, neuroimaging methods, geriatric psychiatry, and mood disorders. His most recent work focuses on understanding and addressing the so-called “replication crisis”.
Robert Kelly

Docent

Dr Shubulade (aka Lade) Smith is a Consultant Psychiatrist at the South London and Maudsley NHS Foundation Trust and Visiting Senior Lecturer at the Institute of Psychiatry, Psychology and Neuroscience, Kings College London. After training in general psychiatry at the Maudsley, she undertook a Research Fellowship in antipsychotic side effects, supervised by Professor Sir Robin Murray. She was nominated as “Woman of the Year” and a BMA Pioneer award for innovation in psychiatry for her “one-stop shop” joint physical-mental health clinic. Dr Smith is the Lead for the Acute Forensic Pathway of the South London Partnership and Clinical Director of the Forensic Services at SLaM. She is also Clinical and Strategic Director of the National Collaborating Centre  Mental Health at the Royal College of Psychiatrists, providing medical leadership for the team developing mental health guidelines. She sat on the core working group of the UK Independent Mental Health Act Review, chaired by Professor Sir Simon Wessely. Dr Smith was awarded a CBE in the Queen’s Birthday Honours in June 2019 for services to Forensic Psychiatry. In November 2019 she was awarded Psychiatrist of the Year by the Royal College of Psychiatrists.
Her research includes tackling mental health inequality; physical health in SMI; implementation of Advance decisions to reduce involuntary detention and the short-term management of violent behaviour. Dr Smith is a Trustee of National Mind and an advisor to Rethink. She is also a Trustee of the Bethlem Gallery. Dr Smith enjoys walking along London’s river, reading and Zumba.
 
Shubulade Smith

Professor 

Partners/Sponsors

Venue

Elite Hotel Marina Plaza Helsingborg, Sweden

Event Location

Get Directions

Enjoy your stay in Helsingborg

- Digital guide Helsingborg
- Shopping

Where to stay
The conference is held at Elite hotel Marina Plaza, if you whish to book a room please visit: Hotell Helsingborg - Elite Hotel Marina Plaza | Elite Hotell 

How to get to, and get around in, Helsingborg
- Visit Helsingborg

Public transport
- skanetrafiken.se 

Let's Get Social

Region Skåne Koncernkontoret © . All Rights Reserved.
Landing Page Template Designed & Developed By: Saptarang